Jennifer Erensen on Opioid Conversion Guidelines

Article

Jennifer Erensen, associate director of health policy at Purdue Pharma L.P., discusses the clinical study "Review of opioid conversion recommendations from select clinical practice guidelines: all are not equal," presented at the 32nd Annual Scientific Meeting of the American Pain Society.

Jennifer Erensen, associate director of health policy at Purdue Pharma L.P., discusses the clinical study "Review of opioid conversion recommendations from select clinical practice guidelines: all are not equal," presented at the 32nd Annual Scientific Meeting of the American Pain Society.

Related Videos
Related Content

Guselkumab Produces Long-Lasting Pharmacodynamic Effects, Disease Improvement in PsA

September 13th 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Voclosporin Demonstrates Continued Long-Term Safety in Lupus Nephritis

September 12th 2023

Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO

June 29th 2023

Depression Rates Rising Among Younger Patients with IBD-RA

September 8th 2023

Guselkumab Quickly Improves Activities of Daily Living in Patients with PsA

September 8th 2023

Guselkumab Produces Long-Lasting Pharmacodynamic Effects, Disease Improvement in PsA

September 13th 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Voclosporin Demonstrates Continued Long-Term Safety in Lupus Nephritis

September 12th 2023

Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO

June 29th 2023

Depression Rates Rising Among Younger Patients with IBD-RA

September 8th 2023

Guselkumab Quickly Improves Activities of Daily Living in Patients with PsA

September 8th 2023

Guselkumab Produces Long-Lasting Pharmacodynamic Effects, Disease Improvement in PsA

September 13th 2023

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

July 6th 2023

Voclosporin Demonstrates Continued Long-Term Safety in Lupus Nephritis

September 12th 2023

Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO

June 29th 2023

Depression Rates Rising Among Younger Patients with IBD-RA

September 8th 2023

Guselkumab Quickly Improves Activities of Daily Living in Patients with PsA

September 8th 2023
© 2023 MJH Life Sciences

All rights reserved.